Collaboration – September 8, 2026
HeartBeat.bio and Cubase Bio partner to advance 3D spatial transcriptomics
Vienna-based HeartBeat.bio and Stockholm-based Cubase Bio have been awarded roughly EUR 1 million in Eurostars funding to develop a 3D spatial profiling method for studying myocardial fibrosis and heart failure, combining human cardiac organoids with true 3D spatial transcriptomics technology.